Adrienne Victor

Adrienne Victor, M.D., M.S., is an Assistant Professor in the Department of Medicine, Hematology/Oncology division at the University of Rochester School of Medicine and Dentistry. She practices within the UR Medicine Faculty Group (URMFG) and Accountable Health Partners (AHP), providing specialized care in hematology and oncology with clinical expertise in sarcoma, leukemia, and melanoma treatment at Wilmot Cancer Institute.

Her educational foundation includes:

• MD from University of Illinois College of Medicine-Urbana (2012)
• Fellowship in Hematology & Oncology at University of Rochester Medical Center (2015-2018)
• Residency in Internal Medicine at UT Health San Antonio Long School of Medicine (2013-2015)
• Internship in Internal Medicine at UT Health San Antonio Long School of Medicine (2012-2013)

Dr. Victor's research centers on advancing cancer therapeutics, particularly for rare malignancies like retroperitoneal sarcoma and complex interactions between hematologic cancers and solid tumors. Her work bridges clinical oncology with translational research to develop personalized treatment approaches for high-risk patient populations.

Analysis of her publications reveals a strong trajectory in oncology research since 2018, with emphasis on sarcoma and hematologic malignancies, while her earlier neuroscience work demonstrates foundational expertise in molecular mechanisms of disease. Current research priorities focus on neoadjuvant strategies for sarcoma and management of concurrent cancers.

Her distinguished contributions have been recognized through:

• Bennett Travel Award (2017)
• Andrew and Hortense Call Barr Award (2011)
• Ukrainian Medical Association Scholarship (2009-2011)
• Rural Medicine Preceptorship Award (2009)
• Intramural Research Training Award (2004-2006)
• Summer Undergraduate Research Program Award (2003)

As lead researcher for a multicenter Phase III clinical trial on neoadjuvant chemotherapy for retroperitoneal sarcoma, Dr. Victor directs significant research resources investigating whether preoperative treatment improves outcomes in dedifferentiated liposarcoma and leiomyosarcoma. Her patient-centered approach consistently earns exceptional satisfaction ratings, with 4.9/5 stars from 325 reviews highlighting her communication skills and compassionate care.

Dr. Victor operates within the multidisciplinary Hematology/Oncology team at Wilmot Cancer Institute, collaborating with surgical oncologists, radiologists, and pathology specialists to deliver comprehensive cancer care through tumor boards and integrated treatment planning.